Home News & Features

News & Features

3D DNA strands on a technology abstract background

Top 10 Sequencing Companies

Five years after the introduction of the $1,000 genome, the sequencing field remains rife with chatter about pushing the cost much lower—not only to $100...
Prostate cancer cells, illustration

Helomics, SpeciCare Enter Live Tumor Tissue Precision Cancer Care Collaboration

Helomics will provide CRO services and its D-CHIP artificial intelligence (AI) platform for a functional precision medicine study called PIONEER sponsored by SpeciCare.

Flatiron Health, Foundation Medicine Publish Study Validating Clinico-Genomic Database

The study validates that real-world data obtained from routine clinical care to create a multi-institution clinico-genomic database can yield clinically meaningful insights.
Colon cancer. Cancer attacking cell. Colon disease concept

CRC Evades Immunotherapies by Regulating Expression of Cell Surface Molecule

CRC tumors can switch off expression of a cell surface molecule that is a key target of immunotherapy, thus preventing the treatment from working.
Blocked blood vessel 3D render

AI IDs Potentially Life-Threatening Genetic Disease Using EHRs

The classifier could help to flag patients who are most likely to have familial hypercholesterolemia, so that they and their families can undergo further genetic testing.

DNAnexus, UPMC, Sutter Health Launch Clinico-Genomic MS Precision Medicine Study

Clinico-genomic research study aims to improve personalized treatments for people with multiple sclerosis DNAnexus, UPMC, and Sutter Health network said today they have launched a...

Stanford Studies Feasibility of AI Platform for Blood Cancer Precision Treatments

The AI platform from Notable completed personalized treatment recommendations for all 20 patients within 30 days demonstrating both a positive and negative predictive value average of 84 percent.

Evotec, Individumed Partner on Precision Medicine for Colorectal Cancer

Evotec and Individumed said today they will partner to develop new precision therapeutics for colorectal cancer (CRC), through a collaboration whose value was not...
Source: freestylephoto/Getty Images

20 Molecular Diagnostics Companies to Watch

Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
Clinician Offering Drugs Based On DNA Profiling

FDA Sends Warning Letter to Inova Over Pharmacogenomics Test

The agency said it is unaware of data establishing that Inova’s tests helps patients or clinicians make appropriate treatment decisions for the listed drugs.
Scroll Up